ARGORNA Trademark

Trademark Overview


On Thursday, January 23, 2020, a trademark application was filed for ARGORNA with the United States Patent and Trademark Office. The USPTO has given the ARGORNA trademark a serial number of 88770805. The federal status of this trademark filing is REGISTERED as of Tuesday, March 8, 2022. This trademark is owned by GUANGZHOU RIBOBIO CO., LTD.. The ARGORNA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Chemical-pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Drug delivery agents in the form of sterile liquid, sterile freeze-dry powder, emulsion or inhalation for medical purposes that provide controlled release of active ingredients for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, ...
argorna

General Information


Serial Number88770805
Word MarkARGORNA
Filing DateThursday, January 23, 2020
Status700 - REGISTERED
Status DateTuesday, March 8, 2022
Registration Number6662188
Registration DateTuesday, March 8, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements


Goods and ServicesMedicines for human purposes for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Chemical-pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Drug delivery agents in the form of sterile liquid, sterile freeze-dry powder, emulsion or inhalation for medical purposes that provide controlled release of active ingredients for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Veterinary preparations for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm in cats, dogs, horses, chicken and pigs; Medicines for veterinary purposes being preparations for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm in cats, dogs, horses, chicken and pigs; Biological preparations for veterinary purposes for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm; Chemical preparations for veterinary purposes for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm; Preparations for destroying noxious animals, namely, pesticides, insecticides; Preparations for destroying noxious plants, namely, herbicides
Translation of Words in MarkThe wording "ARGORNA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameARGORNA PHARMACEUTICALS LIMITED
Party Type30 - Original Registrant
Legal Entity Type22 - NOT AVAILABLE
AddressHUANGPU DISTRICT, GUANGZHOU n/a
CN

Party NameARGORNA PHARMACEUTICALS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type22 - NOT AVAILABLE
AddressHUANGPU DISTRICT, GUANGZHOU n/a
CN

Party NameGUANGZHOU RIBOBIO CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGuangzhou, Guangdong 510663
CN

Trademark Events


Event DateEvent Description
Tuesday, March 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 23, 2021CASE RETURNED TO EXAMINATION
Thursday, September 23, 2021NOTICE OF ALLOWANCE CANCELLED
Thursday, September 23, 2021PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, September 20, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 14, 2021ASSIGNED TO PETITION STAFF
Tuesday, September 7, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 7, 2021TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, July 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021EXTENSION 2 GRANTED
Tuesday, July 27, 2021EXTENSION 2 FILED
Tuesday, July 27, 2021TEAS EXTENSION RECEIVED
Wednesday, May 12, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2021EXTENSION 1 GRANTED
Monday, January 25, 2021EXTENSION 1 FILED
Monday, January 25, 2021TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Tuesday, August 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 20, 2020EXAMINER'S AMENDMENT ENTERED
Monday, April 20, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 20, 2020EXAMINERS AMENDMENT E-MAILED
Monday, April 20, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, April 13, 2020ASSIGNED TO EXAMINER
Monday, January 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 27, 2020NEW APPLICATION ENTERED IN TRAM